Redwood City, California-based Karius, a provider of liquid biopsy for infectious diseases, has secured $165 million in funding. SoftBank Vision Fund 21 led the round with participation from General Catalyst, HBM Healthcare Investments, Khosla Ventures and LightSpeed Venture Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: